Maritupirdine
A drug under investigation for Alzheimer's disease
Maritupirdine | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Maritupirdine (also known as AVN-101) is a drug that has been under investigation for the treatment of Alzheimer's disease. It is a small molecule that acts as a serotonin receptor modulator, specifically targeting the 5-HT6 receptor.
Mechanism of Action[edit | edit source]
Maritupirdine functions primarily as a 5-HT6 receptor antagonist. The 5-HT6 receptor is a G protein-coupled receptor that is predominantly expressed in the central nervous system, particularly in regions of the brain associated with cognition and memory, such as the cortex and the hippocampus. By blocking this receptor, maritupirdine is thought to enhance the release of neurotransmitters like acetylcholine, dopamine, and glutamate, which are crucial for cognitive processes.
Clinical Development[edit | edit source]
Maritupirdine has been evaluated in several clinical trials to assess its efficacy and safety in patients with Alzheimer's disease. These trials have focused on its potential to improve cognitive function and slow the progression of symptoms associated with the disease. However, as of the latest updates, maritupirdine has not yet received approval for clinical use.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of maritupirdine involves its absorption, distribution, metabolism, and excretion. It is administered orally and is known to cross the blood-brain barrier, allowing it to exert its effects directly on the central nervous system. The drug is metabolized primarily in the liver and excreted through the kidneys.
Potential Side Effects[edit | edit source]
As with many drugs affecting the central nervous system, maritupirdine may have side effects. These can include nausea, headache, dizziness, and insomnia. The safety profile of maritupirdine continues to be evaluated in ongoing studies.
Research and Future Directions[edit | edit source]
Research into maritupirdine is ongoing, with scientists exploring its potential not only for Alzheimer's disease but also for other neurodegenerative disorders and cognitive impairments. The modulation of the 5-HT6 receptor remains a promising target for therapeutic intervention in various cognitive disorders.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD